← All trials
NCT01933815
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2013
- Primary completion
- Feb 1, 2018
- Completion date
- Feb 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 92
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Cortice Biosciences, Inc.Lead sponsor
- University of RochesterOverall official - principal investigator
- Ohio State UniversityOverall official - principal investigator
- Rutgers UniversityOverall official - principal investigator
- Neurological Surgery, P.C.Overall official - principal investigator
- Washington University in St. LouisOverall official - principal investigator
- Memorial Hermann Health SystemOverall official - principal investigator
- University of WashingtonOverall official - principal investigator
- University of Alabama, BirminghamOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.